100 employees
Chemoprotomic and Automation dual-driving platform to expand undruggable target space and drug discovery
2017
$6M
from 1 investors over 1 rounds
Leadart Biotechnologies, Inc. raised $6M on December 28, 2022
Investors: 蓝驰创投中国